Biotechnology to Support Chinese Herbs' Medicinal Claims
The use of herbal medicines, also dubbed as traditional medicine, represents around 40% of the Chinese pharmaceutical market, generating an annual sales of about US$ 21 billion. It is also big in other Asian countries where up to 80% of some populations use it for health care, according to the World Health Organization (WHO). However, it is less accepted elsewhere, partly because of the lack of an evidence base as well as concerns about quality.
But an article in the Bulletin of the World Health Organization reports that Chinese researchers tap biotechnology to improve its drug quality standards and to convince the international research community that traditional Chinese medicine has a solid evidential basis. The Chinese traditional medicine-based research and development, funded by the National Institute of Health of the United States of America, will try to increase the prospects of obtaining biologically active hits to specific diseases, representing a tremendous advantage to drug discovery and development.
For more information, visit http://www.who.int/bulletin/volumes/90/8/12-020812/en/.
This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)
View Crop Biotech Update (
August 10, 2012
) Newsletter
Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS
